CompletedInterventionalNot ApplicableUpdated Oct 31, 2012
Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric | NCT00761488 | Trialant
WithdrawnInterventionalPhase 4Updated May 12, 2015
Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric
ClinicalTrials.gov ID
NCT00761488
Lead Sponsor
Alcon ResearchINDUSTRY
Overall Status
Withdrawn
Study Type
Interventional
Phase
Phase 4
Enrollment
0Actual
Last Update Posted
May 12, 2015Estimated
Brief Summary
To allow surgeons to obtain clinical experience on the postoperative uncorrected and best distance corrected visual acuities (UCVA and BDCVA) and corneal and refractive cylinder of the AcrySof Toric IOL.
Cataract
AcrySof® Toric IOL
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
40-80 years old; of any race and gender; diagnosed with bilateral cataracts; require cataract extraction followed by implantation of a posterior chamber IOL; patients have between 0.75 -2.5 D of astigmatism preoperatively as measured by K readings.
Exclusion Criteria:
Females of child bearing potential;irregular corneal astigmatism;keratopathy/Keratectasia; cornea inflammation or edema;previous corneal reshaping,dystrophy or transplant;amblyopia;glaucoma;RPE/Macular changes;diabetic retinopathy.